On the Use of Nonparametric Curves in Phase I Trials with Low Toxicity Tolerance (Q3078934): Difference between revisions
From MaRDI portal
Created claim: Wikidata QID (P12): Q52044831, #quickstatements; #temporary_batch_1712190744730 |
ReferenceBot (talk | contribs) Changed an Item |
||
| Property / cites work | |||
| Property / cites work: Sequential Designs for Phase I Clinical Trials with Late‐Onset Toxicities / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: A Curve‐Free Method for Phase I Clinical Trials / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Consistency of continual reassessment method under model misspecification / rank | |||
Normal rank | |||
Revision as of 19:20, 3 July 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | On the Use of Nonparametric Curves in Phase I Trials with Low Toxicity Tolerance |
scientific article |
Statements
On the Use of Nonparametric Curves in Phase I Trials with Low Toxicity Tolerance (English)
0 references
1 March 2011
0 references
Bayesian nonparametric estimation
0 references
continual reassessment method
0 references
0 references
